Picture of Allergy Therapeutics logo

AGY Allergy Therapeutics News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

REG - Allergy Therapeutics - Price Monitoring Extension

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220224:nRSX7652Ca&default-theme=true

RNS Number : 7652C  Allergy Therapeutics PLC  24 February 2022
Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users
a further opportunity to review the prices and sizes of orders entered in an
individual security's auction call before the execution occurs. A price
monitoring extension is activated when the matching process would have
otherwise resulted in an execution price that is a pre-determined percentage
above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium
Exchange sector. This is set out in the Sector Breakdown tab of the Parameters
document at www.londonstockexchange.com/tradingservices
(http://www.londonstockexchange.com/tradingservices)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PMEBLGDDLXDDGDS

Recent news on Allergy Therapeutics

See all news